BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19896081)

  • 1. Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children.
    Gruhn B; Intek J; Pfaffendorf N; Zell R; Corbacioglu S; Zintl F; Beck JF; Debatin KM; Steinbach D
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1571-7. PubMed ID: 19896081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant.
    Metafuni E; Giammarco S; Bellesi S; Rossi M; Minnella G; Limongiello MA; Valentini CG; Teofili L; Sica S; Chiusolo P
    Int J Lab Hematol; 2023 Dec; 45(6):935-944. PubMed ID: 37646104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation.
    Hansen JA; Chien JW; Warren EH; Zhao LP; Martin PJ
    Curr Opin Hematol; 2010 Nov; 17(6):483-92. PubMed ID: 20827186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alpha-defensin gene single nucleotide polymorphism modulates the gut microbiota and may alter the risk of acute graft-versus-host disease.
    Rashidi A; Herman A; Gomes ALC; Peled JU; Jenq RR; Brereton DG; Staley C; Blazar BR; Weisdorf DJ
    Br J Haematol; 2020 Jun; 189(5):926-930. PubMed ID: 32086815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Preventions and Treatments of aGVHD: From Pharmacological Prophylaxis to Innovative Therapies.
    Naserian S; Leclerc M; Shamdani S; Uzan G
    Front Immunol; 2020; 11():607030. PubMed ID: 33391276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No role of common NOD2 gene variants in predicting sepsis related outcomes in Indian patients undergoing hematopoietic stem cell transplant.
    Jandial A; Naseem S; Khadwal A; Varma N; Ray P; Singh C; Jain A; Lad D; Malhotra P; Prakash G
    Med J Armed Forces India; 2023; 79(6):689-693. PubMed ID: 37981940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome-wide association study on hematopoietic stem cell transplantation reveals novel genomic loci associated with transplant outcomes.
    Rosenberger A; Crossland RE; Dressel R; Kube D; Wolff D; Wulf G; Bickeböller H; Dickinson A; Holler E
    Front Immunol; 2024; 15():1280876. PubMed ID: 38384455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT.
    Piras IS; Angius A; Andreani M; Testi M; Lucarelli G; Floris M; Marktel S; Ciceri F; La Nasa G; Fleischhauer K; Roncarolo MG; Bulfone A; Gregori S; Bacchetta R
    Bone Marrow Transplant; 2014 Nov; 49(11):1400-1404. PubMed ID: 25111513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in gene therapy for inborn errors of immunity.
    Ott de Bruin LM; Lankester AC; Staal FJT
    Curr Opin Allergy Clin Immunol; 2023 Dec; 23(6):467-477. PubMed ID: 37846903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?
    Alexoudi VA; Gavriilaki E; Cheva A; Sakellari I; Papadopoulou S; Paraskevopoulos K; Vahtsevanos K
    Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab.
    Kroemer A; Belyayev L; Khan K; Loh K; Kang J; Duttargi A; Dhani H; Sadat M; Aguirre O; Gusev Y; Bhuvaneshwar K; Kallakury B; Cosentino C; Houlihan B; Diaz J; Moturi S; Yazigi N; Kaufman S; Subramanian S; Hawksworth J; Girlanda R; Robson SC; Matsumoto CS; Zasloff M; Fishbein TM
    Am J Transplant; 2021 Mar; 21(3):1238-1254. PubMed ID: 32882110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.
    Martínez-Laperche C; Buces E; Aguilera-Morillo MC; Picornell A; González-Rivera M; Lillo R; Santos N; Martín-Antonio B; Guillem V; Nieto JB; González M; de la Cámara R; Brunet S; Jiménez-Velasco A; Espigado I; Vallejo C; Sampol A; Bellón JM; Serrano D; Kwon M; Gayoso J; Balsalobre P; Urbano-Izpizua Á; Solano C; Gallardo D; Díez-Martín JL; Romo J; Buño I;
    Blood Adv; 2018 Jul; 2(14):1719-1737. PubMed ID: 30030270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives.
    Toubai T; Mathewson ND; Magenau J; Reddy P
    Front Immunol; 2016; 7():539. PubMed ID: 27965667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease.
    Malard F; Gaugler B; Lamarthee B; Mohty M
    Mucosal Immunol; 2016 Mar; 9(2):299-308. PubMed ID: 26813345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.
    Teng MW; Bowman EP; McElwee JJ; Smyth MJ; Casanova JL; Cooper AM; Cua DJ
    Nat Med; 2015 Jul; 21(7):719-29. PubMed ID: 26121196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of inflammatory cytokine gene polymorphisms on developing acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation.
    Masetti R; Zama D; Urbini M; Astolfi A; Libri V; Vendemini F; Morello W; Rondelli R; Prete A; Pession A
    J Immunol Res; 2015; 2015():248264. PubMed ID: 25973432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses.
    Maeda Y
    Int J Hematol; 2013 Sep; 98(3):293-9. PubMed ID: 23982970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-host disease biomarkers: omics and personalized medicine.
    Paczesny S; Raiker N; Brooks S; Mumaw C
    Int J Hematol; 2013 Sep; 98(3):275-92. PubMed ID: 23959582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of non-HLA gene polymorphisms in graft-versus-host disease.
    Takami A
    Int J Hematol; 2013 Sep; 98(3):309-18. PubMed ID: 23949916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in predicting acute GVHD.
    Harris AC; Ferrara JL; Levine JE
    Br J Haematol; 2013 Feb; 160(3):288-302. PubMed ID: 23205489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.